Nebenwirkungen · Epysqli
Epysqli 300 mg concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 9–10
HOS-150918 · Präparat HOS-100418
9 MedDRA system Very Common Uncommon Rare Not known organ class common (≥1/100 to (≥1/1 000 to <1/100) (≥1/10000 to (cannot be (≥1/10) <1/10) <1/1000) estimated from the available data) and polyps) Blood and Leukopenia, Thrombocytopenia, Haemolysis*, lymphatic system Anaemia Lymphopenia Abnormal clotting disorders factor, Red blood cell agglutination, Coagulopathy Immune system Anaphylactic reaction, disorders Hypersensitivity Endocrine disorders Grave’s disease Metabolism and Decreased appetite nutrition disorders Psychiatric Insomnia Depression, Abnormal dreams disorders Anxiety, Mood swings, Sleep disorder Nervous system Headache Dizziness Paraesthesia, Tremor, disorders Dysgeusia, Syncope Eye disorders Vision blurred Conjunctival irritation Ear and labyrinth Tinnitus, Vertigo disorders Cardiac disorders Palpitation Vascular disorders Hypertension Accelerated Haematoma hypertension, Hypotension, Hot flush, Vein disorder Respiratory, Cough, Dyspnoea, Epistaxis, thoracic Oropharyngeal pain Throat irritation, Nasal and congestion, mediastinal Rhinorrhoea disorders Gastrointestinal Diarrhoea, Constipation, Gastroesophageal disorders Vomiting, Nausea, Dyspepsia, reflux disease, Abdominal pain Abdominal distension Gingival pain Hepatobiliary Alanine Jaundice Liver disorders aminotransferase injuryd increased, Aspartate aminotransferase increased, Gamma- glutamyltransferase increased Skin and Rash, Pruritus, Urticaria, Skin subcutaneous tissue Alopecia Erythema, depigmentation disorders Petechiae, Hyperhidrosis, Dry skin, Dermatitis Musculoskeletal Arthralgia, Muscle spasms, Trismus, Joint and connective Myalgia, Pain Bone pain, Back swelling tissue disorders in extremity pain, Neck pain Renal and urinary Renal impairment, disorders Dysuria, Haematuria Reproductive Spontaneous penile Menstrual disorder
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-08-07T10:30:00Z · SHA-256 a9eca7e70a0a0f271a11ba447d34aeb489929889650c92e6408edfb4c5b58dde · Passage 2df743935ad0631dc79e5069973f895c09adb60e4c9196b4590c2bc6d3ef7407 · Zeichen 3322–7784 im Abschnitt